High plasma levels of lipids are an important modifiable risk factor for co
ronary heart disease, but are not established as a risk factor for stroke.
Pathophysiologic evidence that links lipids to major systemic artery diseas
e, and the results of clinical trials of coronary heart disease prevention
in relation to lipid-lowering suggest that lipids may play an important rol
e in the causation of stroke. We discuss the controversy concerning plasma
lipids as a risk factor for stroke. A clinical trial targeted at lowering l
evels of lipids with the aim of primary stroke prevention would be a timely
and important contribution. Armed with this information, we could further
clarify the plasma lipid-stroke controversy and move into the 21st century
with a better understanding of stroke prevention. (C) 1999 Lippincott Willi
ams & Wilkins.